How to Value a Pre-Revenue Startup: 5 Methods Compared

A pre-revenue startup is valued by triangulating several rough methods rather than by calculating one answer. The common ones are the Berkus method, the scorecard method, the venture capital method and market comparables. In practice the price is usually set by round math — the amount raised divided by the ownership sold — and the methods are used to defend or challenge that figure.

No formula produces a correct answer here, because there are no cash flows to discount. What follows is how each method works, what it is good for, and how to combine them into a range you can defend across a table.

Why Can't You Value a Pre-Revenue Startup the Normal Way?

Standard valuation needs cash flows, growth rates and a risk measure, and a pre-revenue company has none of the three in usable form. Aswath Damodaran's paper on valuing young and start-up companies sets out the problem: no operating history, little or no revenue, dependence on private capital, and a high chance the company does not survive.

Three consequences for a founder:

Research on investor behaviour points the same way. A survey of 885 institutional venture capitalists found that they weight the management team above the product or technology when selecting investments. The same authors summarise the survey for operators in Harvard Business Review. Their picture of investment selection is a judgement about people and market first, with the spreadsheet second.

So pre-revenue methods do not measure value. They organise a judgement about risk.

How Does the Berkus Method Work?

The Berkus method adds up to $500,000 of value for each of five elements that reduce risk, giving a pre-revenue ceiling of $2 million and a post-rollout ceiling of $2.5 million. Angel investor Dave Berkus created it in the mid-1990s and restated it in his current published version. The five elements:

Two conditions come attached that most summaries leave out. Berkus says the method applies to companies an investor believes can exceed $20 million in revenue by year five. He also says the per-element maximums can be raised to reflect geography or business type, and that the five tests themselves can be swapped — regulatory milestones in place of a prototype for a drug developer, for example.

An illustrative scoring, not a real company: strong idea at $400,000, working prototype at $500,000, incomplete team at $300,000, one pilot partner at $100,000, no rollout at zero. Total: $1.3 million pre-money.

Where it works: Idea-stage and prototype-stage companies talking to angels. It forces a conversation about which risks are actually retired.

Where it breaks: The caps are low against many current coastal pre-seed rounds, and Berkus himself notes that old versions with different numbers still circulate online. Use it to rank risks, and scale the caps to your market before quoting a total.

How Does the Scorecard Method Work?

The scorecard method takes the average pre-money valuation of recently funded pre-revenue companies in your region and adjusts it up or down using weighted factors. Bill Payne developed it for angel groups and set it out in his Scorecard Valuation Methodology paper. His weights:

For each factor you score the company against the regional norm, where 100% means average. Multiply each score by its weight, add the results, and multiply the sum by the average pre-money valuation.

An illustrative run, using a made-up regional average of $2.0 million: team 125%, opportunity 150%, product 100%, competition 75%, channels 80%, further investment 100%, other 100%. The weighted sum is 1.155. The scorecard valuation is $2.31 million pre-money.

Where it works: It is anchored to real local deals, so it travels well between markets. The weighting also tells founders something useful — team and market size together carry more than half the score, and product carries 15%.

Where it breaks: Everything depends on the average you start from. Payne's own survey figures date from 2010 and should not be reused. Pull a current benchmark for your stage and region from a source such as Carta's data desk or the PitchBook-NVCA Venture Monitor before you run the arithmetic.

How Does the Venture Capital Method Work?

The venture capital method works backwards: estimate what the company could be worth at exit, divide by the return the investor needs, and the result is today's post-money valuation. The steps:

Damodaran's paper lists typical target rates of return by stage: 50-70% a year at start-up, 40-60% at first stage, 35-50% at second stage. He also explains why they look so high. The rate has the probability of failure baked into it, and realised venture returns are far lower than the targets.

An illustrative case: an investor believes the company could exit for $100 million and needs 10 times their money. That implies $10 million post-money today. If they expect later rounds to dilute them by half, the figure drops to $5 million post-money. A $1 million cheque then buys 20%, on a $4 million pre-money valuation.

Where it works: It is the only method here that mirrors fund economics. If your exit case cannot support the investor's required return at your asking price, no amount of scorecard arithmetic will change their answer.

Where it breaks: The exit value is a guess, and the two sides have opposite incentives. Damodaran's critique is direct: the founder pushes the exit number up and the target rate down, the investor does the reverse, and the method turns into a bargaining frame.

How Do Market Comparables and Round Math Set the Price?

Most pre-seed valuations are set by round math: the amount you need divided by the ownership the investor requires equals the post-money valuation. Raise $1.5 million from an investor who needs 20% and the post-money is $7.5 million, so the pre-money is $6 million. Nobody ran a model. The valuation fell out of two other numbers.

This is why Y Combinator's seed fundraising guide tells founders not to over-optimise valuation, and why the amount raised and the dilution accepted are the decisions that matter. The mechanics of the pre-money and post-money relationship do the rest.

Market comparables are the sanity check on that figure:

On a SAFE the same logic applies with one twist. The post-money SAFE cap is a post-money number that already includes the SAFE money. An investor putting $1 million into a SAFE with an $8 million post-money cap holds 12.5% before the priced round's new money and option pool. A cap is a valuation, and it should survive the same tests.

Which Valuation Method Should You Use?

Use at least three methods, treat the spread between them as your range, and lead the negotiation with the one your counterparty already uses. Side by side:

A workable sequence for a founder:

Then match the argument to the audience. Angel groups often think in scorecard terms. A seed fund thinks in ownership targets and exit multiples. Presenting a Berkus total to an institutional fund answers a question they did not ask.

Is a 409A Valuation the Same Thing?

No. A 409A valuation sets the fair market value of common stock so that employee options can be granted without a tax penalty, and it is usually lower than the price investors pay. The rules sit in the Treasury regulations under Section 409A, which give a presumption of reasonableness to valuations that follow specified methods, including a qualifying independent appraisal.

The two numbers differ for a structural reason. Investors typically buy preferred stock or an instrument that converts into it, with a liquidation preference and other rights. Employees receive options on common stock, which has none of those. Quoting your 409A figure to an investor understates the company, and quoting your round price as the option strike can create a tax problem for your team.

For the fundraising number, see pre-money valuation explained and how much equity founders give up at seed.

Frequently Asked Questions

How do you value a startup with no revenue?

You triangulate. Score the company with the Berkus and scorecard methods, work backwards from a plausible exit using the venture capital method, and compare the results with recent rounds at the same stage and sector. Then check the range against round math: the amount you are raising divided by the ownership you are selling. The answer is a range to negotiate within, not a single figure.

What is the Berkus method?

The Berkus method is a pre-revenue valuation approach created by angel investor Dave Berkus. It assigns up to $500,000 each to five elements — sound idea, prototype, quality management team, strategic relationships, and product rollout or sales — for a maximum of $2 million pre-revenue or $2.5 million after rollout in its current published form. Berkus notes the caps can be adjusted for region and business type.

What is the scorecard valuation method?

The scorecard method, developed by Bill Payne, starts with the average pre-money valuation of comparable pre-revenue companies in a region and adjusts it using seven weighted factors. Management team carries the most weight at up to 30%, followed by size of the opportunity at up to 25% and product or technology at up to 15%. The result is only as good as the regional average you begin with.

What is a reasonable valuation for a pre-revenue startup?

There is no universal figure. It depends on stage, sector, geography and how competitive the round is. A reasonable valuation is one that sits inside the range of recent comparable rounds, lets you raise enough to reach the next milestone at a dilution you can accept, and still leaves the investor a credible path to their required return.

Do investors use DCF to value pre-revenue startups?

Rarely as the deciding tool. A discounted cash flow needs cash flows, and a pre-revenue company's are entirely forecast, so small assumption changes swing the output widely. Early-stage investors lean on team, market size, ownership targets and exit potential. A DCF can still be useful to a founder as a test of whether the business model works at scale.

Is a SAFE valuation cap the same as a valuation?

Functionally, yes. A post-money SAFE cap fixes the maximum company value at which the SAFE converts, which sets the investor's minimum ownership. A $1 million SAFE on an $8 million post-money cap converts to 12.5% before the priced round's new money. Treat the cap with the same care you would give a pre-money valuation in a priced round.